Nos publications
Mise à jour août 2024
Pagination
- Page précédente
- Page 32
- Page suivante
Title | Authors | Year Trier par ordre croissant | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
Trauma 2021: Trauma Association of Canada Annual Scientific Meeting, Vancouver, British Columbia (virtual), April 12–16, 2021 | Bednarek O, O’Leary M, Hurley S, Cummings C, Bird R, Frattini S, McEachern S, Benjamin S, Pereira A, Brigode W, MacLean A, Moore L, Makish A, Sadler J, Sadler J, Albacete S, Forbes H, Grzelak S, Strauss R, Strauss R, Upadhyaya Y, Leung V, Tropiano J, Moore M, Greene J, Goldstein J, Schmitz E, Bratu I, Alballa AS, Dawe P, Malone J, Javidan AP, Allen L, Curtis RM, Ssebazza K, Schellenberg M, Lampron J, Tanenbaum B, Chisholm A, Ringuette J, Watson I, Shi D, Bhangu A, Moffat B, Fong D, Moore L, Farquharson S, Al Khaboori S, Lorthios-Guilledroit A, Côté C, McPherson J, Tran A, Guttman M, Yeung M, Poirier R-A, Siddiqi M, Evans T, Guiab K, Guiab K, Bradley N, Elliott C, Bradley N, Power A, Kirkpatrick A, Merkle A, Jessula S, Minor S, Emsley J, Sameoto C, Fitzpatrick E, Erdogan M, Lampron J, Green R, Sibley A, Jain T, Nicholson B, Stryhn H, Karsli C, Stuhler R, Ng E, Coates A, Engels P, Benjamin S, Watson I, Watson I, Talsma AN, Lobchuk M, Thongpriwan V, Cahill S, Mis J, Starr F, Bokhari F, Ladak A, Snelgrove R, Wang H, Power H, Bradley N, Allen L, Leeper R, Parry N, Ball I, Vogt K, Moffat B, Rawls D, Dawe P, Ramler G, Andres E, Rawls D, Lakha N, Brisson A, Merchant J, Forbes H, Widder S, Bradley N, Bradley N, Widder S, Albacete S, Berube M, Gagnon M-A, Pelet S, Belzile É, Kron A, Callum J, Armali C, Modi D, Notario L, Perez P, Tillmann B, Pannell D, Beckett A, Tien H, Nathens A, Da Luz L, Perrier L, Menchetti I, Blondal E, Peng H, Sullivan-Kwantes W, Tien H, Nathens A, Beckett A, Callum J, Da Luz L, Irfan N, Coates A, Engels P, Razek T, Wilson A, Beckett A, Goltz D, Figueira S, Knight H, Lampron J, Devine D, Callum J, Jenkins C, Beckett A, Goldstien J, Leroux Y, McVey J, Brown R, Swain J, Carter A, Fidgen D, Baker S, Butts F, McCulloch S, Opra I, Jensen J, Travers A, Andreou P, Earl M, Warner G, Carter A, Rezaaifar M, Figueira S, Wilkins D, Lampron J, Lai K, Hafeez AA, Goldberg S, Abahuje E, Pozner C, Yule S, Parker S, Dias R, Simons R, Joos E, Haines VV, Linder J, Cameron A, Nathens A, Cleghorn G, Chaplin T, Vogt K, Parry N, Priestap F, Leeper R, Mujoomdar A, Kribs S, Ball I, Kearley C, LeBlanc J, Owattanapanich N, Getrajdman J, Matsushima K, Lam L, Inaba K, Figueira S, Eagles D, Khoury L, Nemnom M-J, Moors J, Kriellaars D, Mitchell D, Watson I, Totton L, Ouelett L, Benjamin S, Vautour J, McEachern S, Watson I, Ouelett L, Ringuette J, Chisholm A, Pishe T, McLaren C, Evans C, Notario L, Pannell D, Thomas-Boaz W, Freedman C, Tien H, Nathens A, Da Luz L, Li C, Vogt K, Allen L, Yoshy C, Mujoomdar A, Wiseman D, Mao R, Liu EY, Lan L, Amir T, Yan J, Singh K, Allard-Coutu A, Hameed M, Garraway N, Joos E, Isac G, Kanji H, Finlayson G, Tansley G, Lee A, Gonthier C, Belcaïd A, Moore L, Duranceau M-F, Truchon C, Berube M, Moore L, Lauzier F, Vogt K, Berry G, Tremblay L, Martel M, Pagé G, Belzile É, Pinard A-M, Evans D, Perreault K, Sirois C, Grzelak S, Turgeon A, Talbot M, Kennedy C, Hilsden R, Slobogean G, Lamb T, Lampron J, Matar M, Fernando S, Perry J, Vaillancourt C, Nathens J, Strauss R, Tillmann B, Phillips A, Haas B, Hage B, Yanchar N, Joos E, Brisson A, McKay J, Bryan F, Evans T, Qureshi A, Saadat G, Khalifa A, Bokhari F, Kaminsky M, Guiab K, Khalifa A, Bokhari F, Aly A, Evans T, Roberts A, Khalifa A, Kaminsky M, Bokhari F, Evans T, Zahid J, Roberts A, Saadat G, Messer T, Bokhari F, Keen R, Hoogers K, Widder S, Notario L, Javidan A, Johnston M, Thomas-Boaz W, Freedman C, Pannell D, Tien H, Nathens A, Da Luz L, Morch K, Scott L, Lam N, Widder S, Parekh A, Parry N, Tomlinson C, Donley N, McKee J, Wachs J, Kay M, Holland S | 2021 | Can J Surg | View Trauma 2021: Trauma Association of Canada Annual Scientific Meeting, Vancouver, British Columbia (virtual), April 12–16, 2021 | Health care providers | Basic research |
International Forum on Mitigation Strategies to Prevent Faint and Pre-faint Adverse Reactions in Whole Blood Donors: Responses | Goldman M, Townsend M, Magnussen K, Lozano M, Nissen-Meyer LSH, Lee CK, Leung JN, Takanashi M, McKay J, Kvist M, Robitaille N, Deschênes J, Di Angelantonio E, McMahon A, Roberts D, Maghsudlu M, Castrén J, Tiberghien P, Woimant G, Morel P, Kamel H, Bravo M, Shinar E, Gendelman V, Raz H, Wendel S, Fachini R, Quee F, van den Hurk K, Wiersum J, Grima KM, Speedy J, Bruun MT, Dunbar NM | 2021 | Vox Sang | View International Forum on Mitigation Strategies to Prevent Faint and Pre-faint Adverse Reactions in Whole Blood Donors: Responses | Health care providers | Benchmarking and standard setting |
Psychometric Evaluation of ITP Life Quality Index (ILQI) in a Global Survey of Patients with Immune Thrombocytopenia | Viana R, D'Alessio D, Grant L, Cooper N, Arnold D, Morgan M, Provan D, Cuker A, Hill QA, Tomiyama Y, Ghanima W | 2021 | Adv Ther | View Psychometric Evaluation of ITP Life Quality Index (ILQI) in a Global Survey of Patients with Immune Thrombocytopenia | Researchers | Clinical research |
Definition of a critical bleed in patients with immune thrombocytopenia: Communication from the ISTH SSC Subcommittee on Platelet Immunology | Sirotich E, Guyatt G, Gabe C, Ye Z, Beck CE, Breakey V, Cooper N, Cuker A, Charness J, de Wit K, DiRaimo J, Fein SG, Grace RF, Hassan Z, Jamula E, Kang M, Manski CF, O'Connor C, Pai M, Paynter D, Porter SC, Pruitt B, Strachan G, Webert KE, Yan JW, Kelton JG, Bakchoul T, Arnold DM | 2021 | J Thromb Haemost | View Definition of a critical bleed in patients with immune thrombocytopenia: Communication from the ISTH SSC Subcommittee on Platelet Immunology | Health care providers | Benchmarking and standard setting |
Risk of transfusion-transmitted Babesia microti in Canada | O'Brien SF, Drews SJ, Yi Q-L, Bloch EM, Ogden NH, Koffi JK, Lindsay LR, Gregoire Y, Delage G | 2021 | Transfusion | View Risk of transfusion-transmitted Babesia microti in Canada | Researchers | Benchmarking and standard setting |
Réactions transfusionnelles anaphylactiques et déficit en IgA | Khandelwal A, Clarke G, Goldman M | 2021 | Blood.ca website | View Réactions transfusionnelles anaphylactiques et déficit en IgA | Health care providers | Benchmarking and standard setting |
Factors associated with wrong blood in tube errors: An international case series - The BEST collaborative study | Dunbar NM, Kaufman RM | 2021 | Transfusion | View Factors associated with wrong blood in tube errors: An international case series - The BEST collaborative study | Health care providers | Benchmarking and standard setting |
A comparative study of platelet factor 4-enhanced platelet activation assays for the diagnosis of heparin-induced thrombocytopenia | Rubino JG, Arnold DM, Warkentin TE, Smith JW, Kelton JG, Nazy I | 2021 | J Thromb Haemost | View A comparative study of platelet factor 4-enhanced platelet activation assays for the diagnosis of heparin-induced thrombocytopenia | Researchers | Basic research |
Monocyte monolayer assay predictions of clinical outcome for serologically incompatible red blood cells is all about timing | Branch DR, Sandhu G, Raos M | 2021 | Transfusion | View Monocyte monolayer assay predictions of clinical outcome for serologically incompatible red blood cells is all about timing | Researchers | New or improved product or process |
Donor screening question alternatives to men who have sex with men time deferral: Potential impact on donor deferral and discomfort | O'Brien SF, Goldman M, Robillard P, Osmond L, Myhal G, Roy É | 2021 | Transfusion | View Donor screening question alternatives to men who have sex with men time deferral: Potential impact on donor deferral and discomfort | Blood operators | MSM research |
Pathogen reduction of whole blood: Supplementing fibrinogen partly corrects clot formation in a massive transfusion model | Arbaeen AF, Schubert P, Sheffield WP, Devine DV | 2021 | Transfusion | View Pathogen reduction of whole blood: Supplementing fibrinogen partly corrects clot formation in a massive transfusion model | Researchers | New or improved product or process |
ResearchUnit: Perioperative treatment for patients with immune thrombocytopenia: Eltrombopag vs IVIG | Arnold DM | 2021 | Blood.ca website | View ResearchUnit: Perioperative treatment for patients with immune thrombocytopenia: Eltrombopag vs IVIG | Health care providers | Clinical research |
Heparin-Induced Thrombocytopenia and Vaccine-Induced Immune Thrombotic Thrombocytopenia Antibodies: Fraternal-Not Identical-Twins | Warkentin TE | 2021 | Thromb Haemost | View Heparin-Induced Thrombocytopenia and Vaccine-Induced Immune Thrombotic Thrombocytopenia Antibodies: Fraternal-Not Identical-Twins | Researchers | Clinical research |
Vaccine-induced immune thrombotic thrombocytopenia presenting with normal platelet count | Page D, Zhu N, Sawler D, Sun HW, Turley E, Pai M, Wu C | 2021 | Res Pract Thromb Haemost | View Vaccine-induced immune thrombotic thrombocytopenia presenting with normal platelet count | Researchers | Clinical research |
Teaching bone marrow procedures at pelvic and sternal sites: a high fidelity anatomy simulation | Heather Vander M, Laureano M, Hu G, Lim W, Ross C, Wainman B, Zeller MP | 2021 | Can Med Educ J | View Teaching bone marrow procedures at pelvic and sternal sites: a high fidelity anatomy simulation | Health care providers | Benchmarking and standard setting |
Chaptire 16: Don autologue préopératoire | Foster T, Yan M | 2021 | Guide de la pratique transfusionnelle | View Chaptire 16: Don autologue préopératoire | Health care providers | Benchmarking and standard setting |
External qualification of the Web-Accessible Population Pharmacokinetic Service-Hemophilia (WAPPS-Hemo) models for octocog alfa using real patient data | Chelle P, Hajducek D, Mahdi M, Young S, Iorio A, Silvertown J, Edginton A | 2021 | Res Pract Thromb Haemost | View External qualification of the Web-Accessible Population Pharmacokinetic Service-Hemophilia (WAPPS-Hemo) models for octocog alfa using real patient data | Researchers | New or improved product or process |
Lessons learned in the collection of convalescent plasma during the COVID-19 pandemic | Wendel S, Land K, Devine DV, Daly J, Bazin R, Tiberghien P, Lee C-K, Arora S, Patidar GK, Khillan K, Smid WM, Vrielink H, Oreh A, Al-Riyami AZ, Hindawi S, Vermeulen M, Louw V, Burnouf T, Bloch EM, Goel R, Townsend M, So-Osman C | 2021 | Vox Sang | View Lessons learned in the collection of convalescent plasma during the COVID-19 pandemic | Blood operators | New or improved product or process |
Chapter 11: Massive hemorrhage and emergency transfusion | Trudeau J, Dawe P, Shih A | 2021 | Clinical Guide to Transfusion | View Chapter 11: Massive hemorrhage and emergency transfusion | Health care providers | Benchmarking and standard setting |
Current challenges of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence studies among blood donors: A scoping review | Saeed S, Uzicanin S, Lewin A, Lieshout-Krikke R, Faddy H, Erikstrup C, Osiowy C, Seed C, Steele W, Davidson K, Custer B, O’Brien S, Assessment ObotSR, Policy sub-group of the Transfusion Transmitted Infectious Diseases Working Party of the International Society of Blood Transfusion | 2021 | medRxiv | View Current challenges of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence studies among blood donors: A scoping review | Researchers | Basic research |
International Forum on Walking Blood Bank Programmes: Summary | Martinaud C, Scorer T, Lozano M, Miles A, Fitchett G, Ba A, Wikman A, Nimberger-Hansson P, Enbuske S, Bohon?k M, Devine D, Beckett AN, Mbanya D, T'Sas F, Degueldre J, Chueca M, Dedome E, Apelseth T, Strandenes G, Wendel S, Fachini R, Olszewski A, Dupont C, Glassberg E, Shinar E, Taylor AL, Corley JB, Sekaran Nadarajan V, Dunbar N | 2021 | Vox Sang | View International Forum on Walking Blood Bank Programmes: Summary | Blood operators | Benchmarking and standard setting |
CD248 enhances tissue factor procoagulant function, promoting arterial and venous thrombosis in mouse models | Kapopara PR, Safikhan NS, Huang JL, Meixner SC, Gonzalez K, Loghmani H, Ruf W, Mast AE, Lei V, Pryzdial ELG, Conway EM | 2021 | J Thromb Haemost | View CD248 enhances tissue factor procoagulant function, promoting arterial and venous thrombosis in mouse models | Researchers | Basic research |
Rethinking platelet transfusion practices | Devine DV | 2021 | Blood | View Rethinking platelet transfusion practices | Health care providers | New or improved product or process |
Convalescent plasma for adults with acute COVID-19 respiratory illness (CONCOR-1): Study protocol for an international, multicenter, randomized open-label trial | Bégin P, Callum J, Heddle N, Cook R, Zeller MP, Tinmouth A, Fergusson D, Cushing MM, Glesby MJ, Chassé M, Devine DV, Robitaille N, Bazin R, Shehata N, Finzi A, McGeer A, Scales D, Schwartz L, Turgeon AF, Zarychanski R, Daneman N, Carl R, Amorim L, Gabe C, Ellis M, Jamula E, Carruthers J, Duncan J, Lucier K, Armali C, Kron A, Modi D, Auclair M-C, Avram M, Arnold DM | 2021 | Trials | View Convalescent plasma for adults with acute COVID-19 respiratory illness (CONCOR-1): Study protocol for an international, multicenter, randomized open-label trial | Researchers | Clinical research |
Convalescent plasma for hospitalized patients with COVID-19 and the effect of plasma antibodies: a randomized controlled, open-label trial | Bégin P, Callum J, Jamula E, Cook R, Heddle NM, Tinmouth A, Zeller MP, Beaudoin-Bussières G, Amorim L, Bazin R, Loftsgard KC, Carl R, Chassé M, Cushing MM, Daneman N, Devine DV, Dumaresq J, Fergusson DA, Gabe C, Glesby MJ, Li N, Liu Y, McGeer A, Robitaille N, Sachais BS, Scales DC, Schwartz L, Shehata N, Turgeon AF, Wood H, Zarychanski R, Finzi A, Arnold DM, for The CONCOR-1 Study Group | 2021 | medRxiv | View Convalescent plasma for hospitalized patients with COVID-19 and the effect of plasma antibodies: a randomized controlled, open-label trial | Health care providers | Clinical research |
In Vitro Characterization and Metabolomic Analysis of Cold-Stored Platelets | Zhao HW, Serrano K, Stefanoni D, D’Alessandro A, Devine DV | 2021 | J Proteome Res | View In Vitro Characterization and Metabolomic Analysis of Cold-Stored Platelets | Researchers | Basic research |
Platelet-activating immune complexes identified in critically ill COVID-19 patients suspected of heparin-induced thrombocytopenia | Nazy I, Jevtic SD, Moore JC, Huynh A, Smith JW, Kelton JG, Arnold DM | 2021 | J Thromb Haemost | View Platelet-activating immune complexes identified in critically ill COVID-19 patients suspected of heparin-induced thrombocytopenia | Health care providers | Clinical research |
Selection and in vitro and in vivo characterization of a Kunitz protease inhibitor domain of protease nexin 2 variant that inhibits factor XIa without inhibiting plasmin | Eltringham-Smith LJ, Bhakta V, Sheffield WP | 2021 | J Biotechnol | View Selection and in vitro and in vivo characterization of a Kunitz protease inhibitor domain of protease nexin 2 variant that inhibits factor XIa without inhibiting plasmin | Researchers | Basic research |
Five novel FY null alleles associated with typing discrepancies | Vege S, Floch A, Lomas-Frances C, Clarke G, Westhoff CM | 2021 | Transfusion | View Five novel FY null alleles associated with typing discrepancies | Researchers | Benchmarking and standard setting |
Background incidence rates of hospitalisations and emergency department visits for thromboembolic and coagulation disorders in Ontario, Canada for COVID-19 vaccine safety assessment: a population-based retrospective observational study | Nasreen S, Calzavara AJ, Sundaram ME, MacDonald SE, Righolt CH, Pai M, Field TS, Zhou LW, Wilson SE, Kwong JC | 2021 | BMJ Open | View Background incidence rates of hospitalisations and emergency department visits for thromboembolic and coagulation disorders in Ontario, Canada for COVID-19 vaccine safety assessment: a population-based retrospective observational study | Researchers | Clinical research |
Plateletworks® as a Point-of-Care Test for ASA Non-Sensitivity | Khan H, Jain S, Gallant RC, Syed MH, Zamzam A, Al-Omran M, Rand ML, Ni H, Abdin R, Qadura M | 2021 | J Pers Med | View Plateletworks® as a Point-of-Care Test for ASA Non-Sensitivity | Researchers | New or improved product or process |
Chapter 2: Blood components | Gupta A, Bigham M | 2021 | Clinical Guide to Transfusion | View Chapter 2: Blood components | Health care providers | Benchmarking and standard setting |
Prevention of transfusion-transmitted syphilis by blood operators: How much is enough when transfusion-transmission has not been identified for decades? | Drews SJ | 2021 | Transfusion | View Prevention of transfusion-transmitted syphilis by blood operators: How much is enough when transfusion-transmission has not been identified for decades? | Blood operators | Benchmarking and standard setting |
Necrotizing enterocolitis and mortality after transfusion of ABO non-identical blood | Parvizian MK, Barty R, Heddle NM, Li N, McDougall T, Mukerji A, Fusch C, Solh Z | 2021 | Transfusion | View Necrotizing enterocolitis and mortality after transfusion of ABO non-identical blood | Researchers | Clinical research |
Mechanism of increased efficacy of recombinant Fc-?TP-L309C compared to IVIg to ameliorate mouse immune thrombocytopenia | Lewis BJB, Binnington B, Blacquiere M, Spirig R, Käsermann F, Branch DR | 2021 | eJHaem | View Mechanism of increased efficacy of recombinant Fc-?TP-L309C compared to IVIg to ameliorate mouse immune thrombocytopenia | Researchers | Basic research |
Anti-inflammatory activity of CD44 antibodies in murine immune thrombocytopenia is mediated by Fc? receptor inhibition | Norris PAA, Kaur G, Khan R, Zhu G, Ni H, Lazarus AH | 2021 | Blood | View Anti-inflammatory activity of CD44 antibodies in murine immune thrombocytopenia is mediated by Fc? receptor inhibition | Researchers | Basic research |
Evidence of SARS-CoV-2 Infection in Cells, Tissues, and Organs and the Risk of Transmission Through Transplantation | Gaussen A, Hornby L, Rockl G, O’Brien S, Delage G, Sapir-Pichhadze R, Drews SJ, Weiss MJ, Lewin A | 2021 | Transplantation | View Evidence of SARS-CoV-2 Infection in Cells, Tissues, and Organs and the Risk of Transmission Through Transplantation | Health care providers | Clinical research |
Circular of information for the use of human blood components: Hematopoietic Progenitor Cells (HPC), Cord Blood | Jenkins C | 2021 | Blood.ca website | Health care providers | Benchmarking and standard setting | |
The SSC platelet immunology register of VITT and VIITP: Toward standardization of laboratory and clinical parameters | Choi PY, Grace RF, Therese Ahlen M, Nazy I, Sachs UJ, Arnold DM, McKenzie SE, Althaus K, Sharma R, Bakchoul T | 2021 | J Thromb Haemost | View The SSC platelet immunology register of VITT and VIITP: Toward standardization of laboratory and clinical parameters | Researchers | Benchmarking and standard setting |
ResearchUnit: Intravenous albumin is not associated with improved outcomes in cardiac surgery patients | Bartoszko J | 2021 | Blood.ca website | View ResearchUnit: Intravenous albumin is not associated with improved outcomes in cardiac surgery patients | Health care providers | Clinical research |
FAQ: Canadian Blood Services Platelet Bacterial Testing | Khandelwal A, Ramirez-Arcos S, Bigham M | 2021 | Blood.ca website | View FAQ: Canadian Blood Services Platelet Bacterial Testing | Health care providers | Other |
Déclaration des réactions transfusionnelles indésirables | Yan M | 2021 | Blood.ca website | View Déclaration des réactions transfusionnelles indésirables | Health care providers | Benchmarking and standard setting |
The impact of extended half-life factor concentrates on patient reported health outcome measures in persons with hemophilia A and hemophilia B | Sun HL, Yang M, Poon MC, Lee A, Robinson KS, Sholzberg M, Wu J, Iorio A, Blanchette V, Carcao M, Klaassen RJ, Jackson S | 2021 | Res Pract Thromb Haemost | View The impact of extended half-life factor concentrates on patient reported health outcome measures in persons with hemophilia A and hemophilia B | Researchers | Clinical research |
Implementation of measures to reduce vasovagal reactions: Donor participation and results | Goldman M, Uzicanin S, Marquis-Boyle L, O'Brien SF | 2021 | Transfusion | View Implementation of measures to reduce vasovagal reactions: Donor participation and results | Health care providers | Clinical research |
Combined preoperative plasma exchange and red blood cell exchange transfusion in a renal transplant patient with protein S deficiency and hemoglobin SC disease | Cook O, Cervi A, Laureano M, Gangji AS, Verhovsek M | 2021 | Transfus Apher Sci | View Combined preoperative plasma exchange and red blood cell exchange transfusion in a renal transplant patient with protein S deficiency and hemoglobin SC disease | Researchers | Clinical research |
Concentré de recherche: Suggestion concernant le mécanisme en jeu dans la thrombocytopénie thrombotique induite par le vaccin | Batarfi K | 2021 | Blood.ca website | View Concentré de recherche: Suggestion concernant le mécanisme en jeu dans la thrombocytopénie thrombotique induite par le vaccin | Researchers | Clinical research |
Evidence of SARS-CoV-2 Infection in Cells, Tissues and Organs and the Risk of Transmission Through Transplantation | Gaussen A, Hornby L, Rockl G, O'Brien S, Delage G, Sapir-Pichhadze R, Drews SJ, Weiss MJ, Lewin A | 2021 | Transplantation | View Evidence of SARS-CoV-2 Infection in Cells, Tissues and Organs and the Risk of Transmission Through Transplantation | Health care providers | Clinical research |
International survey on Helicobacter pylori testing in patients with immune thrombocytopenia: Communication of the platelet immunology scientific and standardization committee | Vishnu P, Duncan J, Connell N, Cooper N, Lim W, Rodeghiero F, Tomiyama Y, Grace RF, Bakchoul T, Arnold DM | 2021 | J Thromb Haemost | View International survey on Helicobacter pylori testing in patients with immune thrombocytopenia: Communication of the platelet immunology scientific and standardization committee | Health care providers | Benchmarking and standard setting |
Terminal half-life of FVIII and FIX according to age, blood group and concentrate type: Data from the WAPPS database | Versloot O, Iserman E, Chelle P, Germini F, Edginton AN, Schutgens REG, Iorio A, Fischer K | 2021 | J Thromb Haemost | View Terminal half-life of FVIII and FIX according to age, blood group and concentrate type: Data from the WAPPS database | Researchers | Clinical research |
Antibody and cellular therapies for treatment of covid-19: a living systematic review and network meta-analysis | Siemieniuk RA, Bartoszko JJ, Díaz Martinez JP, Kum E, Qasim A, Zeraatkar D, Izcovich A, Mangala S, Ge L, Han MA, Agoritsas T, Arnold D, Ávila C, Chu DK, Couban R, Cusano E, Darzi AJ, Devji T, Foroutan F, Ghadimi M, Khamis A, Lamontagne F, Loeb M, Miroshnychenko A, Motaghi S, Murthy S, Mustafa RA, Rada G, Rochwerg B, Switzer C, Vandvik PO, Vernooij RW, Wang Y, Yao L, Guyatt GH, Brignardello-Petersen R | 2021 | BMJ | View Antibody and cellular therapies for treatment of covid-19: a living systematic review and network meta-analysis | Researchers | Clinical research |